IDEXX Laboratories Files 2024 10-K
Ticker: IDXX · Form: 10-K · Filed: Feb 21, 2025 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 10-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, diagnostics
Related Tickers: IDXX
TL;DR
IDXX 10-K filed: Full 2024 financials & biz details out. Check it.
AI Summary
IDEXX Laboratories Inc. filed its 2024 10-K on February 21, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in Westbrook, Maine, operates in the in vitro and in vivo diagnostic substances sector. The filing covers financial performance and business operations for the period.
Why It Matters
This filing provides investors and analysts with a comprehensive overview of IDEXX Laboratories' financial health, strategic initiatives, and risk factors for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a public company filing a 10-K, there are inherent risks related to market conditions, competition, and regulatory changes that affect financial performance.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-21 — Filing Date (Date the 10-K was submitted to the SEC)
- 2024-01-01 — Fiscal Year Start (Beginning of the reporting period)
Key Players & Entities
- IDEXX LABORATORIES INC /DE (company) — Filer
- 0000874716 (company) — Central Index Key
- 2835 (company) — Standard Industrial Classification
- DE (company) — State of Incorporation
- WESTBROOK (company) — City
- ME (company) — State
- Jonathan W. Ayers (person) — Member
FAQ
What was IDEXX Laboratories' total revenue for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What are the primary business segments of IDEXX Laboratories as detailed in the 10-K?
The filing indicates operations in 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' and mentions 'Product' and 'Service' segments.
When was the company incorporated and where is its headquarters located?
IDEXX Laboratories Inc. was incorporated in Delaware (DE) and its headquarters are located in Westbrook, Maine (ME).
Who is listed as a member in relation to the company's reporting periods?
Jonathan W. Ayers is listed as a member, with reporting periods associated with him from October 1, 2024, to December 31, 2024, and January 1, 2024, to December 31, 2024.
What is the Standard Industrial Classification (SIC) code for IDEXX Laboratories?
The SIC code for IDEXX Laboratories is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 21, 2025 by Jonathan W. Ayers regarding IDEXX LABORATORIES INC /DE (IDXX).